Abstract Details

Title Long Term Outcomes and Risk Factors for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors

Topic Child Neurology and Developmental Neurology

Presentation(s) S46 - (-)

Poster/Presentation
Number 006

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Tejaswi Kandula PRESENTER	No disclosure on file
Michelle A. Farrar	Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Michelle A. Farrar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Matthew C. Kiernan, MBBS, PhD, FRACP (Brain and Mind Centre)	The institution of Prof. Kiernan has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for British Medical Journal Publishers (UK).
	No disclosure on file
	No disclosure on file
Arun Krishnan, MD	Dr. Krishnan has nothing to disclose.
	No disclosure on file
	No disclosure on file

��ɫ����